Dr. Essam Hamza reports

TREATMENT.com AI INC. ANNOUNCES A NEW M&A CREDIT FACILITY

Treatment.com AI Inc. has entered into an M&A (merger and acquisition) credit facility to finance transaction expenses and closing costs associated with acquisitions such as Rocket Doctor. The credit facility is up to $1.5-million at an annual interest rate of 12 per cent and for a term of 18 months. The credit facility is unsecured and is repayable in cash only and no securities of the company are issuable in connection with the facility. Dr. Essam Hamza, chief executive officer of Treatment.com AI, comments, "We are pleased to have a non-dilutive credit facility to assist the company in financing our growth through accretive, revenue-building acquisitions."

About Treatment.com AI Inc.

Treatment.com AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively disrupt the health care sector and impact current inefficiencies and challenges. With the input of hundreds of health care professionals globally, Treatment has built a comprehensive, personalized health care AI engine, the Global Library of Medicine (GLM). Providing highly qualified clinical information and support to all health care professionals, as well as providing recommended tests (physical and lab), X-rays and billing codes. The GLM helps health care professionals (doctor, nurse or pharmacist) reduce their administrative burden; create more time for needed face to face patient appointments and has the propensity for greater consistency in quality of patient support. Treatment's GLM platform also brings the possibility of health equity and inclusion for disenfranchised communities.

We seek Safe Harbor.